Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Organogenesis Holdings Inc (ORGO)

10.67   0.26 (2.5%) 01-27 05:47
Open: 10.4 Pre. Close: 10.41
High: 10.89 Low: 10.2
Volume: 554,014 Market Cap: 1,363M
Organogenesis Holdings, Inc. is a regenerative medical company. The company is headquartered in Canton, Massachusetts and currently employs 700 full-time employees. The firm focuses on the development, manufacture and commercialization of product solutions for the advanced wound care, surgical and sports medicine markets. The company also provides integrated healing solutions that substantially improve medical outcomes. The Company’s advanced wound care and surgical & sports medicine products include PuraPly, Antimicrobial (PuraPlyAM), PuraPly, Affinity, NuShield, Apligraf and Dermagraft. The firm is offering a portfolio of bioactive and acellular biomaterials products in advanced wound care and surgical biologics, including orthopedics and spine. The Company’s comprehensive portfolio is designed to treat a variety of patients with repair and regenerative needs.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 10.9 - 10.953 10.953 - 10.999
Low: 10.079 - 10.137 10.137 - 10.188
Close: 10.58 - 10.673 10.673 - 10.754

Technical analysis

as of: 2021-01-26 4:47:21 PM
Overall:       
Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 13.00     One year: 15.18
Support: Support1: 7.82    Support2: 5.77
Resistance: Resistance1: 11.13    Resistance2: 13.00
Pivot: 8.90
Moving Average: MA(5): 10.50     MA(20): 8.51
MA(100): 5.25     MA(250): 4.39
MACD: MACD(12,26): 1.20     Signal(9): 1.02
Stochastic oscillator: %K(14,3): 85.60     %D(3): 83.29
RSI: RSI(14): 74.12
52-week: High: 11.13  Low: 2.47  Change(%): 125.6
Average Vol(K): 3-Month: 72002  10-Days: 151454

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
ORGO has closed below upper band by 17.7%. Bollinger Bands are 263.6% wider than normal. The large width of the bands suggest high volatility as compared to ORGO's normal range. The bands have been in this wide range for 24 bars. This is a sign that the current trend might continue.

Headline News

Sun, 24 Jan 2021
Organogenesis Holdings Inc. - Consensus Indicates Potential 50.2% Upside - DirectorsTalk Interviews

Fri, 22 Jan 2021
Organogenesis Holdings Inc. - Consensus Indicates Potential 12.8% Upside - DirectorsTalk Interviews

Thu, 21 Jan 2021
Is Organogenesis Holdings Inc (ORGO) Stock About to Get Hot Thursday? - InvestorsObserver

Wed, 20 Jan 2021
Is Organogenesis Holdings Inc (ORGO) the Top Pick in the Drug Manufacturers - Specialty & Generic Industry? - InvestorsObserver

Wed, 20 Jan 2021
Leerink Partners Stick to Their Buy Rating for Organogenesis Holdings Inc By Investing.com - Investing.com

Mon, 18 Jan 2021
Did Organogenesis Holdings' (NASDAQ:ORGO) Share Price Deserve to Gain 80%? - Simply Wall St

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Neutral Price to Earnings: Outperform
Return on Equity: Outperform Debt to Equity: Outperform
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Drug Manufacturers General Specialty & Generic
Shares Out. (M) 128
Shares Float (M) 24
% Held by Insiders 55.51
% Held by Institutions 27.48
Shares Short (K) 320
Shares Short P. Month (K) 508

Stock Financials

EPS -0.050
EPS Est This Year
EPS Est Next Year
Book Value (p.s.) 0.610
Profit Margin -1.61
Operating Margin 1.27
Return on Assets (ttm) 1.1
Return on Equity (ttm) -12.6
Qtrly Rev. Growth 56.8
Gross Profit (p.s.) 1.449
Sales Per Share 2.397
EBITDA (p.s.) 0.090
Qtrly Earnings Growth
Operating Cash Flow (M) -26
Levered Free Cash Flow (M) -50

Stock Valuations

PE Ratio -213.40
PEG Ratio
Price to Book value 17.49
Price to Sales 4.45
Price to Cash Flow -52.65

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.